CVS Health (NYSE:CVS) is facing lawsuits from multiple health systems that allege the company diverted hundreds of millions ...

Eli Lilly and Company said Monday evening that it will soon end 340B discount pricing for some of the hospitals that have not ...

Eli Lilly said last night it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation ...

Eli Lilly moves to deny 340B discounts to hospitals refusing to submit claims data under its documentation policy, escalating ...

Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which ...

B 2026 tracking litigation highlights drugmaker mandates and legal challenges reshaping hospital drug pricing and compliance risks.

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb ...

Effective compliance now spans transaction eligibility, OPAIS synchronization, Medicaid exclusion validation, cost-report ...

It will be used for Pascan’s growing scheduled cargo operations on behalf of a global integrator within eastern Canada, as ...

New York lawmakers won't pass a 340B drug program protection bill this session, disappointing hospitals and health centers ...

Eli Lilly gives hospitals 5 days to submit claims data or lose access to discounted 340B drug pricing, enforcing new transparency rules.

With post-pandemic Medicaid enrollments on the decline and expected to fall further, revenue cycle leaders warn that ...